GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vectus Biosystems Ltd (ASX:VBS) » Definitions » Accounts Payable & Accrued Expense

Vectus Biosystems (ASX:VBS) Accounts Payable & Accrued Expense : A$0.22 Mil (As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Vectus Biosystems Accounts Payable & Accrued Expense?

Vectus Biosystems's quarterly accounts payable & accrued expense increased from Dec. 2022 (A$0.16 Mil) to Jun. 2023 (A$0.25 Mil) but then declined from Jun. 2023 (A$0.25 Mil) to Dec. 2023 (A$0.22 Mil).

Vectus Biosystems's annual accounts payable & accrued expense declined from Jun. 2021 (A$0.35 Mil) to Jun. 2022 (A$0.15 Mil) but then increased from Jun. 2022 (A$0.15 Mil) to Jun. 2023 (A$0.25 Mil).


Vectus Biosystems Accounts Payable & Accrued Expense Historical Data

The historical data trend for Vectus Biosystems's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vectus Biosystems Accounts Payable & Accrued Expense Chart

Vectus Biosystems Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Accounts Payable & Accrued Expense
Get a 7-Day Free Trial 1.14 0.62 0.35 0.15 0.25

Vectus Biosystems Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.76 0.15 0.16 0.25 0.22

Vectus Biosystems Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.


Vectus Biosystems (ASX:VBS) Business Description

Industry
Traded in Other Exchanges
N/A
Address
3-11 Primrose Avenue, Rosebery, Sydney, NSW, AUS, 2018
Vectus Biosystems Ltd is an emerging biotechnology company based in Sydney, Australia. The company is in the process of developing a treatment for fibrosis and high blood pressure, which includes heart, kidney, and liver diseases. The company has also developed a technology aimed at improving the speed and accuracy of measuring the amount of DNA and RNA in samples tested in laboratories.

Vectus Biosystems (ASX:VBS) Headlines

No Headlines